Evidence map›Paper›PMID 22130676›Full record

ArticleThe Journal of biological chemistry2012

Novel mechanism for Fc{epsilon}RI-mediated signal transducer and activator of transcription 5 (STAT5) tyrosine phosphorylation and the selective influence of STAT5B over mast cell cytokine production.

Nicholas A Pullen, Brian O Barnstein, Yves T Falanga, Zhengqi Wang, Ryo Suzuki, Tenchee D Lama Tamang, Michele C Khurana, Emily A Harry, Petr Draber, Kevin D Bunting and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Anaphylaxis: Focus on Transcription Factor Activity.International journal of molecular sciences · 2021
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 4 countries.

Nicholas A PullenDepartment of Biology, Virginia Commonwealth University, Richmond, Virginia 23284, USA.
Brian O Barnstein
Yves T Falanga
Zhengqi Wang
Ryo Suzuki
Tenchee D Lama Tamang
Michele C Khurana
Emily A Harry
Petr Draber
Kevin D Bunting
Kazuya Mizuno
Bridget S Wilson
John J Ryan
Virginia Commonwealth University · USEmory University · USCzech Academy of Sciences, Institute of Molecular Genetics · CZNational Institutes of Health · USTokyo Metropolitan Institute of Medical Science · JPUniversity of New Mexico · US

Funding

Virginia Commonwealth University IRADCAK12GM093857 · NIGMS · VIRGINIA COMMONWEALTH UNIVERSITY · PI DANIEL C BULLARD, John J Ryan · 2010 to 2026
$7.0M
STAT5 Structure-Function in HematopoiesisR01DK059380 · NIDDK · EMORY UNIVERSITY · PI BUNTING, KEVIN D · 2002 to 2017
$4.2M
IL-10 Regulates Mast Cell Function and SurvivalR01AI059638 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI RYAN, JOHN J · 2007 to 2017
$3.8M
Mapping for Specialized Domains for FCeRI Signaling & InternalizationR01AI051575 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI WILSON, BRIDGET S · 2003 to 2013
$3.3M
Functional Analysis of the Sulfotransferase, SULT2B1F32GM065794 · NIGMS · INSTITUTE FOR CANCER RESEARCH · PI GEESE, WILLIAM J · 2002 to 2002
$31k
NIAID NIH HHS 1R01 AI59638NIAID NIH HHS AI051575NIAID NIH HHS R01 AI051575NIAID NIH HHS R01 AI059638NIDDK NIH HHS R01 DK059380NIDDK NIH HHS R01DK059380NIGMS NIH HHS F32 GM065794NIGMS NIH HHS GM065794NIGMS NIH HHS K12 GM093857PHS HHS U19A1077435
6 · The paper itself

Abstract

Previous studies indicate that STAT5 expression is required for mast cell development, survival, and IgE-mediated function. STAT5 tyrosine phosphorylation is swiftly and transiently induced by activation of the high affinity IgE receptor, FcεRI. However, the mechanism for this mode of activation remains unknown. In this study we observed that STAT5 co-localizes with FcεRI in antigen-stimulated mast cells. This localization was supported by cholesterol depletion of membranes, which ablated STAT5 tyrosine phosphorylation. Through the use of various pharmacological inhibitors and murine knock-out models, we found that IgE-mediated STAT5 activation is dependent upon Fyn kinase, independent of Syk, PI3K, Akt, Bruton's tyrosine kinase, and JAK2, and enhanced in the context of Lyn kinase deficiency. STAT5 immunoprecipitation revealed that unphosphorylated protein preassociates with Fyn and that this association diminishes significantly during mast cell activation. SHP-1 tyrosine phosphatase deficiency modestly enhanced STAT5 phosphorylation. This effect was more apparent in the absence of Gab2, a scaffolding protein that docks with multiple negative regulators, including SHP-1, SHP-2, and Lyn. Targeting of STAT5A or B with specific siRNA pools revealed that IgE-mediated mast cell cytokine production is selectively dependent upon the STAT5B isoform. Altogether, these data implicate Fyn as the major positive mediator of STAT5 after FcεRI engagement and demonstrate importantly distinct roles for STAT5A and STAT5B in mast cell function.

Indexed as

Adaptor Proteins, Signal TransducingAgammaglobulinaemia Tyrosine KinaseAnimalsCells, CulturedCholesterolCytokinesJanus Kinase 2Mast CellsMiceMice, KnockoutPhosphatidylinositol 3-KinasesPhosphoproteinsPhosphorylationProtein-Tyrosine KinasesProtein Tyrosine Phosphatase, Non-Receptor Type 6Proto-Oncogene Proteins c-aktAdaptor Proteins, Signal TransducingAgammaglobulinaemia Tyrosine KinaseBtk protein, mouseCholesterolCytokinesFyn protein, mouseGab2 protein, mouseJak2 protein, mouseJanus Kinase 2lyn protein-tyrosine kinasePhosphatidylinositol 3-KinasesPhosphoproteinsProtein-Tyrosine KinasesProtein Tyrosine Phosphatase, Non-Receptor Type 6Proto-Oncogene Proteins c-aktProto-Oncogene Proteins c-fynPtpn6 protein, mouseReceptors, IgEsrc-Family KinasesStat5a protein, mouseStat5b protein, mouseSTAT5 Transcription Factor

Identifiers

PMID22130676
PMCPMC3265884
OpenAlexW2108896153

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.